Tag Archives: King Pharmaceuticals

Pfizer agreed on Tuesday to buy King Pharmaceuticals, a maker of pain medications, for $3.6 billion in cash, in the drug maker’s first major deal since its blockbuster purchase of Wyeth last year. Under the terms of the agreement, Pfizer will begin a tender offer in which it will pay $14.25 a share in cash, a 40 percent premium to ... Read More »